Decode Your
Cancer Genomics Define Your Path.

Independent, ethical, AI-powered interpretation of your NGS, ctDNA, PGx, and hereditary reports.

Book Discovery Call Explore Full Services List

About This Service

I offer a personalized, AI-enhanced, and genomically-guided cancer consultation service. I simplify complex genetic and molecular reports, explain therapeutic options, and deliver a clear, actionable care strategy—independently. This service empowers you to understand your cancer's biology and make informed decisions alongside your oncology care team.


Step 01

Discovery Call

This initial 15–20 minute video call helps us understand your cancer case, available genetic reports, and treatment priorities. We do not offer any treatment recommendation at this stage but instead design a personalized service plan.
Step 02

Precision Oncology Pack

Based on the discovery call outcome, we may proceed with a tailored interpretation of your genetic and clinical data. If additional testing is needed, we coordinate this via certified labs like MedGenome. Final deliverables include full reports, actionable insights, and variant monitoring updates.

Services Categorized and Defined

NGS, ctDNA, PGx, Hereditary Review
Comprehensive review of all genetic panels to identify clinically significant variants.

  • TMB & Neoantigen Prediction
    Estimates Tumor Mutational Burden and neoantigen load to predict immunotherapy success.
  • Immunotherapy Profiling
    Analysis of PD-L1, MSI, TMB for checkpoint inhibitor eligibility.
  • Targeted & Hormonal Therapy Matching
    Links actionable mutations with approved or investigational therapies.
  • Resistance Mutation Detection
    Detection of secondary mutations that limit therapy efficacy and suggesting alternatives.
  • CAR-T/TIL Readiness
    HLA typing and immunogenicity scoring for suitability in advanced cell therapies.
  • Drug Repurposing Insight
    Literature-backed suggestions for off-label or emerging drug uses.
  • Pathway Activation Scoring
    Multi-omic scoring to understand which cancer pathways are driving tumor progression.
  • AI-powered VUS Reclassification & Alerts
    Ongoing monitoring and reevaluation of Variants of Uncertain Significance.
  • Annual Variant Re-evaluation
    Scheduled review of past variants to integrate latest research and trials.
  • PGx-based chemo risk planning
    Genetic risk prediction for chemo toxicity (e.g., TPMT, DPYD).
  • Radiogenomic compatibility check
    Aligning radiation therapy plans with radiosensitivity markers.
  • Therapy line sequencing (1st–4th)
    Roadmap for best treatment order based on resistance evolution.
  • Drug–Drug Interaction Modeling
    AI model checks for adverse interactions in polypharmacy settings.
  • RT + Sensitizer / IO Recommendations
    Combining radiation with sensitizers or immunotherapy based on profile.
  • Post-relapse pivot plans
    Advising new lines of treatment post-resistance or relapse.
  • PGx-safe supportive drug use
    Personalized pre-medication planning (e.g., antiemetics, steroids).
  • ctDNA/MRD trend monitoring
    Longitudinal analysis of circulating tumor DNA for relapse prediction.
  • Theranostic eligibility
    Check for ligands/receptors (e.g., PSMA) for radioligand therapy.
  • Survivorship planning
    Creating health maintenance plans based on somatic/germline risk.
  • Wearables and digital tools
    Guidance on devices/apps that support treatment adherence and monitoring.
  • Dual-format reports
    Separate, customized formats for patients and clinicians.
  • Tumor board summaries
    Single-page clinical summaries for MDT or tumor board presentation.
  • Annual Re-analysis Add-on
    Keeps your report up-to-date with new science, trials, and drugs.
  • Hereditary Cancer Risk Analysis
    BRCA, Lynch, and other syndrome testing and interpretation.
  • Cascade Testing Blueprint
    Support for testing and informing family members of shared risk.

🔍 Why This Service Matters

Without Precision Insight:  confusion, toxicity risk, generalized therapy.

With This Practice: plain explanations, matched therapies, PGx-safe plans, reanalysis updates.

Why My Guidance Matters

Without My Guidance

  • Standard protocols can feel like a one-size-fits-all approach.
  • Treatment is often reactive, changing only after a therapy fails.
  • Valuable genetic data may be overlooked or underutilized.
  • The journey can feel fragmented between different specialists.

With My Guidance

  • Your plan is hyper-personalized to your unique biology.
  • Your roadmap is proactive, with future steps planned in advance.
  • Every piece of data is analyzed for maximum insight and opportunity.
  • I act as a central hub, integrating insights for your entire care team.

Your Journey Begins With a Conversation

Being with me means you are heard. During our initial in-depth conversation, you will submit all the reports you hold. I take the time to understand your complete medical history, your personal story, and your immediate concerns. From this first moment, you have a dedicated partner to translate complexity into clarity and navigate the path ahead.

Creating Your Personal Blueprint for Clarity

Being with me means finding clarity in complexity. Based on our initial review, if there are gaps in the information, I will propose further tests needed to build a high-resolution, multi-dimensional blueprint of your cancer. This isn’t just ‘data’; it’s the foundational knowledge that empowers every subsequent decision, giving you an unparalleled level of control and understanding.
NGS, ctDNA, PDx & Hereditary Review If needed, I orchestrate a suite of advanced tests. This includes Next Generation Sequencing (NGS) of the tumor, analysis of circulating tumor DNA (ctDNA) from a blood sample, and Pharmacogenomics (PGx) to understand how your body processes drugs. This creates a complete picture of the cancer’s drivers and your unique genetic makeup.

Discovering Pathways to Hope

Being with me means seeing possibility where others see complexity. My expertise and AI-powered systems delve deep into your blueprint, connecting millions of data points to find pathways forward. This analysis is a meticulous search for hope, identifying the tumor’s precise vulnerabilities and uncovering every possible avenue for effective treatment.

Informing Your Treatment Options: A 360° View

My analysis doesn’t exist in a vacuum. It is designed to provide powerful insights that inform the full spectrum of cancer care, empowering you and your oncologist to make the most informed decisions for every modality of treatment.
Surgical & Radiation Therapy
Surgical GuidanceMy analysis can help assess the risk of recurrence post-surgery and determine if pre- or post-operative personalized therapy is needed to improve outcomes.
Radiation Therapy PersonalizationBy analyzing your tumor’s genomic radiosensitivity & radiosusceptibility, I can guide decisions about radiation dosage, location, and combination with other therapies for maximum effect.
Chemotherapy & Advanced Treatments
Chemotherapy OptimizationYour personal genetic profile (PGx) can predict your risk of severe toxicity from many standard drugs and help your doctor tailor dosing for safer, more tolerable experiences.
Targeted & Hormonal Therapy MatchingI regularly include whole exome molecular characterization to turn up novel options that can be aligned to target therapies, including both approved and emerging therapies.
Immunotherapy ProfilingI analyze key biomarkers like PD-L1, Microsatellite Instability, and MSI to provide clear evidence of whether your immune system can be activated to fight the cancer.
Drug Repurposing InsightMy systems continuously scan digital research databases to find innovative treatment ideas or safe existing drugs in new ways that could benefit your specific cancer profile.

Co-Creating Your Personalized Roadmap

Being with me means you are an active partner in your own care. I consolidate all of this deep analysis into a strategic treatment roadmap, designed ‘with’ you and your care team. This plan is built around your life, prioritizing maximum efficacy while actively managing your safety, comfort, and peace of mind.

Empowering You and Your Circle of Support

Being with me means your entire support system is empowered. I translate my complex findings into clear, actionable insights for you, your family, and your doctors. Knowledge is shared, questions are answered, and everyone is equipped to support you with clarity and confidence.

A Lifelong Partnership in Your Wellbeing

Being with me means you are never alone on this journey. My commitment extends far beyond the initial plan. I become your long-term partner in health, continuously monitoring, adapting to new science, and supporting you as you move into survivorship and beyond.

With Me, You Are More Than a Patient. You Are a Partner. Your journey is unique, and your care should be too. From the first conversation to long-term survivorship, I am here to provide clarity, hope, and unwavering support. This is my promise to you.

For Educational and Research Use Only The information and services described on this page are provided for educational and research purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. All treatment decisions must be made in consultation with a qualified physician. My services are designed to provide supplementary information to support, not replace, the critical relationship and decisions made between a patient and their doctor.

✅ Journey Conclusion

With Me, You Are More Than a Patient. You Are a Partner.
Your journey is unique, and your care should be too. From the first conversation to long-term survivorship, I am here to provide clarity, hope, and unwavering support.
Take the first step toward confident decision-making

Ready to Begin?

Book Discovery Call

⚠ Medical Disclaimer

The information and services described are for educational and research purposes only, not a substitute for professional medical advice. All decisions must be made with your physician.

Contact With Me.